TCL Archive Center Directors Solidly opposed To Core grant changes, Ask Upton, NCAB To Find Other Solutions November 11, 1977
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive “With resources now constrained, the ability of NCI to be responsive to its constituencies has been compromised.” July 7, 1995
TCL Archive Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed October 8, 1976
TCL Archive In Brief: FASEB Recommends $11.75 Billion NIH Budget; Natcher Wins House Appropriations Chairmanship December 11, 1992
